ETF PROAI

JDOCvsPJP

JPMorgan Healthcare Leaders ETF against Invesco Dynamic Pharmaceuticals ETF — the fee, the flows, the book, and a year head-to-head.

One year, growth of $100
JDOC 111PJP 128Oct 25Oct 26GROWTH OF $100
Head to head
JDOCPJP
Expense ratio0.65%0.57%
Assets$9048.54T$557M
Net flow, 1 month—+$42M
Net flow, 1 year−$25K+$203M
Return, YTD+2.9%+15.6%
Return, 1 year+10.6%+28.0%
Avg daily volume24142K
Holdings6723
ListedOct 31, 2023Jun 23, 2005
Options marketNoYes

MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS

THE DESK BRIEF

Flows, fee cuts, and closure risk on the funds you watch — every trading morning.